HOME >> BIOLOGY >> NEWS
ACS News Service Weekly PressPac -- March 28, 2007

ome scientists dismissed the original 1989 cold fusion experiments by Stanley Pons and Martin Fleischmann as "bad" science due to alleged errors in calorimetric systems, or heat measurement, that could have led to erroneous reports that the excess heat produced was nuclear in origin.

Using more precise calorimetric techniques, a new study by Fleischmann and colleague Melvin Miles reports evidence that the excess heat generated is nuclear and not the result of calorimetric errors. "Our work shows that cold fusion effects are real, but we cannot assess if this excess heat can become useful. Much more research work is needed to answer such questions," says co-author Miles.

CONTACT:
Melvin H. Miles, Ph.D.
University of LaVerne in Calif.
LaVerne, Calif.
Phone: Office: 760-375-9258
Email: mmiles@ulv.edu


ARTICLE # 6 EMBARGOED FOR 9 A.M., EASTERN TIME, April 2, 2007

Leveraging Disorder
Chemical & Engineering News

One of the basic tenets of biology is that the structure of a protein determines its function, but intrinsically disordered proteins, which are unstructured or contain highly unstructured regions, dont seem to follow this rule. Now, a growing number of researchers are finding that these disordered proteins have important biological functions and are involved in disease processes ranging from cancer to Alzheimers disease. An article on these mysterious proteins is scheduled for the April 2 issue of Chemical & Engineering News, the ACS weekly newsmagazine.

Researchers now believe that these disordered proteins confer plasticity and flexibility to proteins, thereby allowing the signaling networks these proteins control to rapidly respond to their cells environment, according to the article by C&EN Associate Editor Sarah Everts. She interviewed several scientists who have provided new insights into these fasc
'"/>

Contact: Michael Woods
m_woods@acs.org
202-872-4400
American Chemical Society
28-Mar-2007


Page: 1 2 3 4 5 6 7 8

Related biology news :

1. ACS News Service Weekly PressPac -- May 23, 2007
2. ACS News Service Weekly PressPac -- May 16, 2007
3. ACS News Service Weekly PressPac -- May 9, 2007
4. ACS News Service Weekly PressPac -- May 2, 2007
5. ACS News Service Weekly PressPac -- April 25, 2007
6. ACS News Service Weekly PressPac -- April 18, 2007
7. ACS News Service Weekly PressPac -- April 11, 2007
8. ACS News Service Weekly PressPac -- March 21, 2007
9. ACS News Service Weekly PressPac -- March. 14, 2007
10. ACS News Service Weekly PressPac -- Feb. 21, 2007
11. ACS News Service Weekly PressPac -- February 14, 2007

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: ACS News Service Weekly PressPac March

(Date:12/17/2014)... DENVER , Dec. 16, 2014  Automation ... is this more evident than at international borders. ... secure document scanners have allowed veteran travelers to ... Automated Passport Control (APC) Kiosks at an increasing ... the globe. According to ...
(Date:12/11/2014)... , Dec. 10, 2014  That blood pressure plays a ... while. Hypertension – the medical term for high blood pressure ... 1800s, and the inflatable cuff that,s used in measuring blood ... mean there,s nothing new about hypertension, its triggers and its ... about the condition and the best ways to treat it. ...
(Date:12/10/2014)... 9, 2014  Wake Forest Baptist Medical Center today announced ... School of Medicine. Funding for this $50 million capital ... will be publicly launched next summer. ... former 60 series R.J. Reynolds Tobacco Company complex, adjacent ... begin immediately with plans to be ready to welcome ...
Breaking Biology News(10 mins):Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4
(Date:12/17/2014)... USA (PRWEB) December 16, 2014 ... manager at Philipps- Universität Marburg’s Department of Physics, ... photonics, in the newly released SPIE Women ... never be too shy to ask questions.” , ... technology, engineering, and mathematics) occupations ranging from university ...
(Date:12/17/2014)... N.J. (PRWEB) December 17, 2014 ... (Euronext: IPN; ADR: IPSEY), today announced ... (referred to as Somatuline®) was approved by the ... treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in adult ... advanced or metastatic disease to improve progression-free survival ...
(Date:12/17/2014)... 17, 2014 This report is ... Tubing industry. For an overview analysis, the report ... industry chain structure, industry overview, policy analysis, and ... industry has witnessed rapid development with key ... acquisitions. This report mentions quartz tubing upstream raw ...
(Date:12/17/2014)... (PRWEB) December 17, 2014 Gene ... that it has entered into a technology access ... (ADM) to apply DNA2.0’s proprietary protein engineering technology, ... process. , “We are extremely excited that the ... platform. This proprietary bioengineering technology has now ...
Breaking Biology Technology:Network, Multitask, Persevere: SPIE Women in Optics Planner Subjects Share from Experience 2Network, Multitask, Persevere: SPIE Women in Optics Planner Subjects Share from Experience 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 82020 Quartz Tubing Market: Global Development & Forecasts Analysis Now at DeepResearchReports.com 2ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2
Cached News: